Market Digest: NVO, BAC, USB, HLT
Source link
Fermion and Simcere Enter into Exclusive License and Collaboration Agreement for First SSTR4 Agonist Disease Targeting in China Via Investing.com
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceuticals (TADAUL:) Group Limited (HKEX: 2096) announced a partnership to develop a clinical-stage disease treatment asset,…